Dr Lal Pathlabs (LPL) has acquired 100% stake in Suburban Diagnostics (SD) Key points to note SD is a Sequoia supported entity, who had put in Rs 40 crore into the Company in 2012. Sequoia had been drawing up an exit plan – explored IPO route previously and recently the more recently the Company was … Read more
Earlier on January 17, 2021, Metropolis Healthcare had approved the acquisition of Hitech Diagnostic Centre and its arm Centralab Healthcare Services in a combination of cash and equity shares deal. At that time, it was cash consideration of Rs 511 crore and equity consideration of up to 4,95,000 fully paid-up equity shares of Rs 2 each. Now the … Read more
The U.S. Food and Drug Administration (FDA) has approved Guardant Health’s liquid biopsy, Guardant360® CDx, for tumor mutation profiling in patients across all solid cancers. For Guardant Health Asia, Middle East and Africa (AMEA), this FDA approval represents a landmark achievement of the Guardant360 test. Currently, the liquid biopsy is commercially available in 41 countries in … Read more